European Idiopathic Pulmonary Fibrosis (IPF) Patient Charter. SIGN UP NOW!

Idiopathic Pulmonary Fibrosis (IPF) is a chronic and ultimately fatal lung disease, the cause of which is still unknown

European IPF Patient Organisations call for patients and their families to have consistent and fair rights to:

  • Early and accurate diagnosis
  • Equal access to care
  • A holistic approach to standardise IPF management
  • Comprehensive and high quality information about the condition
  • Better access to palliative care and end-of-life care

Idiopathic Pulmonary Fibrosis is a chronic, progressive, unpredictable and ultimately fatal lung disease. Currently, between 80,000 and 111,000 (1) people are living with IPF in Europe. This fatal condition has been around for decades, yet there is no cure and only limited treatment available. IPF often develops rapidly and many patients are given a survival time of just two to five years. Each year around 35,000 people in Europe are newly diagnosed with IPF, with this number likely to increase in the future.

The European IPF Patient Charter calls for greater awareness of IPF and for better access to care in European countries. The Charter lays down recommendations that, if adopted, would ensure improvements in IPF patients’ quality of life, whilst supporting efforts to find a cure.

Read the Charter


Latest From The Blog

EU-IPFF launches the first European Consultation Guide on Idiopathic Pulmonary Fibrosis

September 27th, 2017|0 Comments

Brussels, Belgium : The European Idiopathic Pulmonary Fibrosis; The 16 September 2017 Related Disorders Federation [...]

Listen for the Sounds of IPF website

September 27th, 2017|0 Comments

Listen for the Sounds of IPF is a global awareness campaign highlighting the importance of [...]

Ospedale San Giuseppe

July 31st, 2016|0 Comments

Multimedica S.p.A. Presidio Ospedale San Giuseppe - Ospedale Classificato - Unità Operativa di Pneumologia has [...]